NYU and UCLA Awarded $2.4M from NIH to Further Study the Use of Non-Psychotropic Cannabinoids to…
...pain for patients, but up until now they have come with undesirable psychotropic side effects—patients “get high.” “We have developed a novel class of drugs, peripherally-restricted cannabinoids (PRCBs), that…